[go: up one dir, main page]

GB0130388D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0130388D0
GB0130388D0 GBGB0130388.2A GB0130388A GB0130388D0 GB 0130388 D0 GB0130388 D0 GB 0130388D0 GB 0130388 A GB0130388 A GB 0130388A GB 0130388 D0 GB0130388 D0 GB 0130388D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0130388.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GBGB0130388.2A priority Critical patent/GB0130388D0/en
Publication of GB0130388D0 publication Critical patent/GB0130388D0/en
Priority to AU2002352388A priority patent/AU2002352388A1/en
Priority to PCT/GB2002/005675 priority patent/WO2003051871A1/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0130388.2A 2001-12-19 2001-12-19 Compounds Ceased GB0130388D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0130388.2A GB0130388D0 (en) 2001-12-19 2001-12-19 Compounds
AU2002352388A AU2002352388A1 (en) 2001-12-19 2002-12-13 N-aroyl cyclic amine derivatives and their use as orxin receptor antagonist
PCT/GB2002/005675 WO2003051871A1 (en) 2001-12-19 2002-12-13 N-aroyl cyclic amine derivatives and their use as orxin receptor antagonist

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0130388.2A GB0130388D0 (en) 2001-12-19 2001-12-19 Compounds

Publications (1)

Publication Number Publication Date
GB0130388D0 true GB0130388D0 (en) 2002-02-06

Family

ID=9927953

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0130388.2A Ceased GB0130388D0 (en) 2001-12-19 2001-12-19 Compounds

Country Status (3)

Country Link
AU (1) AU2002352388A1 (en)
GB (1) GB0130388D0 (en)
WO (1) WO2003051871A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0218326D0 (en) * 2002-08-07 2002-09-11 Glaxo Group Ltd Compounds
WO2004033418A2 (en) 2002-10-11 2004-04-22 Actelion Pharmaceuticals Ltd. Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
BRPI0508263B8 (en) 2004-03-01 2021-05-25 Idorsia Pharmaceuticals Ltd 1, 2, 3,4-tetrahydro-isoquinoline derivatives, pharmaceutical composition, and use of 1, 2, 3,4-tetrahydro-isoquinoline derivative
EP1932839A4 (en) 2005-09-06 2014-09-10 Shionogi & Co Indolecarboxylic acid derivative having pgd2 receptor antagonistic activity
ES2379744T3 (en) 2007-05-23 2012-05-03 Merck Sharp & Dohme Corp. Pyridyl-piperidine antagonists of orexin receptors
ES2375334T3 (en) 2007-12-28 2012-02-28 Actelion Pharmaceuticals Ltd. COMPOSITE OF 3,4-DIHIDRO-1H-ISOQUINOLINE TRISUBSTITUIDA, PROCEDURE FOR PREPARATION AND USE.
EP3454857A1 (en) 2016-05-10 2019-03-20 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of autoimmune inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000047576A1 (en) * 1999-02-12 2000-08-17 Smithkline Beecham Plc Cinnamide derivatives as orexin-1 receptors antagonists
CN100393703C (en) * 2000-03-14 2008-06-11 埃科特莱茵药品有限公司 Derivatives of 1,2,3,4-tetrahydroisoquinoline

Also Published As

Publication number Publication date
AU2002352388A1 (en) 2003-06-30
WO2003051871A1 (en) 2003-06-26

Similar Documents

Publication Publication Date Title
GB0126433D0 (en) Compounds
GB0124463D0 (en) Compounds
GB0101996D0 (en) Organtic compounds
GB0102668D0 (en) Compounds
GB0112324D0 (en) Compounds
GB0102665D0 (en) Compounds
GB0102673D0 (en) Compounds
GB0119474D0 (en) Compounds
GB0130388D0 (en) Compounds
GB0118364D0 (en) Compounds
GB0115178D0 (en) Compounds
GB0120344D0 (en) Compounds
GB0105098D0 (en) Compounds
GB0121485D0 (en) Compounds
GB0104396D0 (en) Compounds
GB0116059D0 (en) Compounds
GB0115863D0 (en) Compounds
GB0115438D0 (en) Compounds
GB0118994D0 (en) Compounds
GB0114291D0 (en) Compounds
GB0119399D0 (en) Compounds
GB0111760D0 (en) Compounds
GB0111189D0 (en) Compounds
GB0111184D0 (en) Compounds
GB0111183D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)